Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 49.60 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:06 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

orchid chemicals & pharma (OCP) Snapshot

Open
50.60
Previous Close
50.25
Day High
50.85
Day Low
49.30
52 Week High
07/15/14 - 85.45
52 Week Low
05/13/15 - 46.80
Market Cap
4.2B
Average Volume 10 Days
609.8K
EPS TTM
--
Shares Outstanding
85.3M
EX-Date
09/13/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORCHID CHEMICALS & PHARMA (OCP)

Related News

No related news articles were found.

orchid chemicals & pharma (OCP) Related Businessweek News

No Related Businessweek News Found

orchid chemicals & pharma (OCP) Details

Orchid Chemicals & Pharmaceuticals Limited, an integrated pharmaceutical company, is engaged in the research, development, manufacture, marketing, and export of active pharmaceutical ingredients (APIs) and finished dosage forms worldwide. Its API product portfolio includes oral cephalosporins, injectable cephalosporins, carbapenems, non-antibiotics, penicillins, and veterinary products. The company also offers anti-infectives, anti-inflammatory, central nervous system, cardio vascular system, nutraceutical, other oral and sterile products, anti-diabetic formulations, and neuropsychiatry system formulations, as well as nutritional supplements. In addition, it provides new drug discovery, novel drug delivery systems, and contract research and manufacturing services. Orchid Chemicals & Pharmaceuticals Limited was founded in 1992 and is headquartered in Chennai, India.

4,455 Employees
Last Reported Date: 08/27/12
Founded in 1992

orchid chemicals & pharma (OCP) Top Compensated Officers

Managing Director, Executive Director, Chairm...
Total Annual Compensation: 74.2M
Compensation as of Fiscal Year 2013.

orchid chemicals & pharma (OCP) Key Developments

Orchid Chemicals & Pharmaceuticals Limited. Reports Unaudited Standalone Earnings Results for the Quarter and Audited Standalone and Consolidated Earnings Results for the Eighteen Months Ended March 31, 2015

Orchid Chemicals & Pharmaceuticals Limited. reported unaudited standalone earnings results for the quarter and audited standalone and consolidated earnings results for the eighteen months ended March 31, 2015. For the quarter, on standalone basis, the company reported total operating income of INR 3,047.782 million compared to INR 4,527.257 million a year ago. Profit from operations before other income, interest and exceptional items was INR 266.861 million compared to INR 512.405 million a year ago. Loss from ordinary activates before tax was INR 1,787.125 million compared to INR 597.081 million a year ago. Net loss was INR 1,480.496 million or INR 17.36 per basic and diluted share after extra ordinary items (not annualized) compared to INR 807.915 million or INR 11.47 per basic and diluted share after extra ordinary items (not annualized) a year ago. For the eighteen months, on standalone basis, the company reported total operating income of INR 17,537.260 million, profit from operations before other income, interest and exceptional items of INR 400.231 million, loss from ordinary activities before tax of INR 6,534.096 million and net loss of INR 1,910.40 million or INR 26.11 per basic and diluted share after extra ordinary items (not annualized). Earnings before interest, depreciation and tax (EBITDA) stood at INR 3,610 million compared to INR 1,696.0 million registered during the fiscal year 2013. For the eighteen months, on consolidated basis, the company reported total operating income of INR 17,641.406 million, profit from operations before other income, interest and exceptional items of INR 342.452 million, loss from ordinary activities before tax of INR 6,592.095 million and net loss of INR 1,966.522 million or INR 26.88 per basic and diluted share after extra ordinary items (not annualized).

Orchid Chemicals & Pharmaceuticals Limited Announces Board Changes

Orchid Chemicals & Pharmaceuticals Limited announced that Shri R Kannan has been appointed as an independent, non-executive director and Ms. Soundara Kumar has been appointed as a nominee of the Lenders as per the CDR package. She would be a non-executive director on the Board of Orchid. Shri S Yuvaraj an independent member on the Board vacates the Office of Director.

Orchid Chemicals & Pharmaceuticals Limited to Report 18 Months Period Ending Mar 31, 2015 Results on May 28, 2015

Orchid Chemicals & Pharmaceuticals Limited announced that they will report 18 months, period ending Mar 31, 2015 results on May 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCP:IN 49.60 INR -0.65

OCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CF Industries Holdings Inc $315.88 USD -5.77
PhosAgro OAO 2,001 RUB -41.00
Potash Corp of Saskatchewan Inc C$39.14 CAD -1.08
Saudi Arabian Mining Co SR47.62 SAR +1.00
Mosaic Co/The $45.85 USD -0.68
View Industry Companies
 

Industry Analysis

OCP

Industry Average

Valuation OCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORCHID CHEMICALS & PHARMA, please visit www.orchidpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.